OncoChem is pioneering a breakthrough theranostic approach against metastatic pancreatic cancer, one of the deadliest and most treatment-resistant oncological diseases.

Precision medicines for cancer

Maximizing the potential of organoids could unlock new industrial and clinical applications. Orgonex is determined to tackle major challenges preventing successful translation.

PacingCure develops gene therapies for common cardiac arrhythmias and cardiomyopathies

Panorama Laboratories is building a new class of lab devices. Instead of measuring characteristics of samples, we measure characteristics of protocols while they are being executed. These devices will allow for instant and objective documentation of high impact actions in the lab.

Pectcof technology unlocks the potential of the coffee pulp as a source of bio based materials, at the same time detoxifying the waste stream produced by the second most traded commodity in the world.

Radiology is becoming the bottleneck in oncological care, delaying treatment decisions. Our AI technology detects subtle changes, provides precise assessments of lesion progression, and ensures no new lesions are overlooked.

PlateletDx is developing a breakthrough blood test that detects minimal residual disease earlier and more sensitively than existing approaches by analysing tumour-educated blood platelet RNA signatures.

Chronic obstructive pulmonary disease (COPD) stands as the world's third leading cause of death, lacking a cure to date. Our pioneering efforts focus on developing a small molecule targeting a novel protein involved in the restoration of ciliated cells within COPD airways.

Easy & accurate long-term monitoring for Atrial Fibrillation. By providing unobtrusive, long-term monitoring and reliable diagnosis, Praxa Sense offers a solution to detect heart rhythm diseases in an early stage, preventing up to 9 strokes each day in The Netherlands alone.